cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5281/zenodo.5760899
title: PhenoApp Input/Output files

description: With the ongoing cost decrease of genotyping and sequencing technologies, accurate and fast phenotyping remains the bottleneck in the utilizing of plant genetic resources for breeding and breeding research. Although cost-efficient high-throughput phenotyping platforms emerged during the last decades for specific traits and/or species, manual phenotyping is still predominant and a time- and money-consuming task. Approaches that improve data recording, processing or handling are pivotal steps towards an efficient usage of genetic resources and demanded by the research community. Therefore, we developed PhenoApp, an open source Android app for tablets and smartphones to facilitate the digital recording of phenotypical data in the field and greenhouse. It is a versatile tool, that offers the possibility to fully customize own descriptors/scales for any possible scenario or the usage of pre-integrated ready-to-use BBCH scales for apple, cereals, grapevine, maize, potato, rapeseed and rice. Additional BBCH scales can easily be added. Furthermore, the simple and adaptable structure of input and output files enables an easy data handling by either spreadsheet software or even the integration in the workflow of laboratory information management systems (LIMS). The embedding in international information standards such as MIAPPE or the implementation regarding FAIR data principles is feasible. PhenoApp is a decisive contribution to increase efficiency of digital data acquisition in breeding, breeding research and genebank management by accelerating the labor intensive and time-consuming acquisition of phenotyping data.
DOI: 10.5281/zenodo.6433389
title: Pyroconvection Classification based on Atmospheric Vertical Profiling Correlation with Extreme Fire Spread Observations

description: 1. Isochrones for Martorell, Santa Coloma Queralt, Torroella, Pobla Massaluca and Sierra Bermeja fires, in shapefile format. Each file has associated an attribute table identifying the hour (in UTC), the affected area, the rate of spread, and direction. Source: Catalan Fire and Rescue Service (Bombers de la Generalitat de Catalunya) 2. ERA5 reanalysis data obtained for each fire, hourly and at different pressure levels (37) from the Copernicus Climate Change Service (C3S) Climate Data Store (CDS). The files are in netCDF format, and the variables requested were temperature, relative humidity, U-component of wind, V-component of wind. Source: Hersbach, H., Bell, B., Berrisford, P., Biavati, G., Horányi, A., Muñoz Sabater, J., Nicolas, J., Peubey, C., Radu, R., Rozum, I., Schepers, D., Simmons, A., Soci, C., Dee, D., Thépaut, J-N. (2018): ERA5 hourly data on pressure levels from 1979 to present. Copernicus Climate Change Service (C3S) Climate Data Store (CDS). 10.24381/cds.bd0915c6 3. Data from sondes launched in fires during the 2021 Spain wildfire campaign. The files are in CSV format, and there are two per fire: the sounding data corrected and the raw flight history. The information provided is Hour (UTC), Wind speed (m/s), Wind direction (true deg), Dew point (C), Latitude, Longitude, Altitude (in m MSL and m AGL), Pressure (Pascal), Speed (m/s), Heading (degrees), Temperature (C), Relative humidity (%), Internal temperature (C), Latitude, Longitude, Rise speed (m/s). Source: Catalan Fire and Rescue Service (Bombers de la Generalitat de Catalunya) 4. Data from the closest weather station to each fire. The file is an Excel file. The table fields are: fire name, weather station name, day, hour, average temperature (°C), maximum temperature(°C), minimum temperature (°C), average relative humidity (%), precipitation (mm), wind speed (10 m, km/h), wind direction (10 m, degrees), wind gusts (10 m, km/h), pressure (hPa), radiation (W/m). Source: Meteo.cat, Servei Meteorològic de Catalunya 5. Fire behavior resume for Martorell, Santa Coloma Queralt, Torroella, Pobla Massaluca, Llançà, Alfarràs and Sierra Bermeja fires (Spain). The differences in the data shown respond to the possibility of launching sondes, recreating isochrones, and observing the plume column during each fire. In those cases where the information was obtained through these three ways, the variables available are: column type, ABL and LCL height (m), sonde ID, rate of spread (km/h), ROS observed / ROS expected ratio, fireline intensity expected and observed (kW/m), and affected area (ha). 6. Photographic registry of the fire plume evolution and a brief description of the pyroconvective moments in the Alfarràs, Martorell, Llançà, Torroella, Santa Coloma de Queralt, Pobla Massaluca, and Sierra Bermeja fires (Spain). Pictures sources: Catalan Fire and Rescue Service (Bombers de la Generalitat de Catalunya)
DOI: 10.5281/zenodo.7130224
title: Data and codes

description: DFT VASP data and MATLAB codes.
DOI: 10.5517/ccdc.csd.cc1p9kzj
title: CCDC 1558338: Experimental Crystal Structure Determination

description: Related Article: Qiang  Liu|2017|CSD Communication|||
DOI: 10.6084/m9.figshare.19638783.v1
title: Bugula_SD2019_MASTER.xls

description: Raw data from experiment examining resistance to copper toxicity across generations and populations in a common fouling organism <em>Bugula neritina. </em>Settling success, survival counts, and growth data (number of bifurcations) are recorded each week for six weeks.
DOI: 10.17632/kjjrrxddbr.1
title: Dataset on thermal properties, sound reductions, TVOC emissions, and costs of envelope components for prefabricated buildings in Australia

description: The data included in the dataset are related to prefabricated building components and their specifications. The specification provided are component type, material, thickness, density, thermal conductivity, specific heat, sound reduction index, total volatile organic compounds (TVOC) emissions and costs in various locations of Australia. The components that are included in this dataset are wall cladding, wall core, interior wall lining, insulation, roof cladding, floor covers and glazing. The authors attempted to cover most of the available component types and their available thicknesses. However, the authors acknowledge that due customisability of these products, other variations of the materials and their dimensions may have not been mentioned in the dataset. For some materials the specifications related to certain properties could net be accessed. Therefore, this dataset is designed to be open for updates and further development in the future. The dataset has been used in sets of building envelope design optimisation practices as input parameters.
DOI: 10.15139/s3/lqtwtc
title: Replication Data for: Measuring and Explaining the Power of State Senate Leadership

description: Theories that explain the power of legislative leaders have been developed for the U.S. Congress and lower chambers of state legislatures, but they have not been tested for state senates, even though senate leaders can be quite influential. Following Mooney (2013a), I use data from the Book of States to develop a new numerical index score measuring the formal power of the top chamber-elected leader of each state senate from 1995 through 2010. I then use the data to test various hypotheses explaining variation in the power of legislative leaders. The results uncover partial evidence for conditional party government theory, but only for senates that elect their own president. When the lieutenant governor serves as senate president, senators do not perceive their top chamber-elected leader (either the president pro tem or the majority leader) as an officer able to best carry out their ideological, electoral, or policy objectives. This underscores crucial differences between senate chambers that elect their own presidents and those that do not.
DOI: 10.5281/zenodo.7133387
title: Environmental, grain size, and shoreline data from Point Hope, Alaska, USA

description: Numerous datasets and a numerical modeling tool are included for characterizing oceanographic conditions, geologic properties, and morphologic changes at Point Hope, Alaska, USA. Newly digitized shorelines, provided as a single shapefile, of the instantaneous water line are provided from the period of 2004 to 2021 for characterizing recent and historical beach changes along the northern shore of the Point Hope spit. Still water level data collected from within Marryat Inlet from summer and fall 2021 are included for characterizing astronomical tides and other non-tidal residuals that contribute to these shoreline change patterns. This time series data is given as an excel file. Text files of wave time series from an offshore Spotter wave buoy from summer and fall 2021 is also provided. Grain size information from two sites are provided for additional site context, also provided as an excel spreadsheet. These various inputs are incorporated into a numerical tool, based on the Palmsten and Holman (2012), dune erosion model. An example script is provided to set up, run, and visualize model scenarios. These analytical model scripts are coded in Matlab. These datasets and modeling outputs are presented in a paper "Assessing drivers of coastal tundra retreat along Point Hope, Alaska" submitted to the Journal of Geophysical Research: Earth Surface in June 2022.
DOI: 10.17632/3jwwbth9th.1
title: Dual-output rectifier triple-MOSFETs switch for triboelectric nanogenerator

description: The video is the change of temporary capacitances’ voltage. The timing when the two surfaces contact is the timing the capacitances discharging, which proved that the maximum capacitance tracking is realized.
DOI: 10.3886/e178142v1
title: Code for: Dynamic Matching in Overloaded Waiting Lists

description: Simulation code for "Dynamic Matching in Overloaded Waiting Lists". The code simulates buffer-queue mechanisms can calculates objects of interest, such as welfare.
DOI: 10.5281/zenodo.1240534
title: Detection Of Structural Components In Point Clouds Of Existing Rc Bridges

description: <em>The cost and effort </em><em>of</em><em> modelling existing bridges from point clouds currently outweighs the perceived benefits of the resulting model. There is a pressing need to automate this process. Previous research has achieved the automatic generation of surface primitives combined with rule-based classification to create labelled cuboids and cylinders from point clouds. While these methods work well in synthetic datasets or idealized cases, they encounter huge challenges when dealing with real-world bridge point clouds, which are often unevenly distributed and suffer from occlusions. In addition, real bridge geometries are complicated. In this paper, we propose a novel top-down method to tackle these challenges for detecting slab, pier, pier cap, and girder components in reinforced concrete bridges. This method uses a slicing algorithm to separate the deck assembly from pier assemblies. It then detects and segments pier caps using their surface normal, and girders using oriented bounding boxes and density histograms. Finally, our method merges over-segments into individually labelled point clusters. The results of 10 real-world bridge point cloud experiments indicate that our method achieves an average detection precision of 98.8%. This is the first method of its kind to achieve robust detection performance for the four component types in reinforced concrete bridges and to directly produce labelled point clusters. Our work provides a solid foundation for future work in generating rich Industry Foundation Classes models from the labelled point clusters.</em>
DOI: 10.5281/zenodo.4550300
title: Multimodal Biomedical Dataset for Evaluating Registration Methods (Full-size TMA Cores)

description: The dataset consists of 206 aligned Bright-Field (BF) and Second-Harmonic Generation (SHG) images. All images are of the same size of 2048x2048 pixels. The training set contains 40 image pairs. The validation set 1 contains 25 image pairs for tuning the training hyperparameters. The validation set 2 contains 7 image pairs for tuning the registration method. The test set contains 134 image pairs for evaluation. Example of the naming convention in the test set: 1B_A1_BF.tif: image in Bright-Field 1B_A1_SHG.tif: image in Second-Harmonic Generation Example of the naming convention in the train/validation sets: 1B_A2_WB.tif: image in Bright-Field 1B_A2_MI.tif: image in Second-Harmonic Generation The dataset was originally produced by the authors of <strong><em>Non-disruptive collagen characterization in clinical histopathology using cross-modality image synthesis</em></strong> (https://www.nature.com/articles/s42003-020-01151-5).
DOI: 10.5281/zenodo.5837936
title: Aerosol Microphysics Emulation Dataset

description: This dataset contains input/output data of one time step of the M7 aerosol microphysics model. It is created to enable the use of machine learning to emulate the model part. It contains input and output pairs for training, validation and testing from separate days of the year. The code can be found here.
DOI: 10.6084/m9.figshare.12237314
title: FGF9 variant in 46,XY DSD patient suggests a role for dimerization in sex determination

description: Supplemetary Material
DOI: 10.15151/esrf-es-1004811608
title: Preparation of experiment A30-2-1162 planned for January 2023 : test of the minicryostat, optimization of the kinetic measurements under x-r

description: Combining photo- and magneto-strictive properties in epitaxial heterostructures provides a versatile approach to optically control magnetic properties through a strain-mediated mechanism. However, a screening of the parameters which govern the mechanical coupling is still required to optimize the response of these heterointerfaces. During this preparation stage, we plan to optimize kinetic measurements on two samples made of Prussian blue analogues and quantify the time scale of the photo-excitation under X-ray irradiation on (1) single-phase photoactive particles (140 nm size) and (2) a core-shell particle sample (170 nm size). No laser will be used for these test experiments. The samples will be directly photo-excited by the incident x-rays.
DOI: 10.25934/pr00006053.10
title: Available IPD datapackage for study 'A Phase III, Open-Label, Multicenter, Randomized Study Evaluating the Efficacy and Safety of Atezolizumab (MPDL3280A, Anti-PD-L1 Antibody) in Combination With Carboplatin+Paclitaxel or Atezolizumab in Combination With Carboplatin+Nab-Paclitaxel Versus Carboplatin+Nab-Paclitaxel in Chemotherapy-Naive Patients With Stage IV Squamous Non-Small Cell Lung Cancer'

description: This randomized, open-label study will evaluate the safety and efficacy of atezolizumab (MPDL3280A) in combination with carboplatin + paclitaxel or carboplatin + nab-paclitaxel compared with treatment with carboplatin + nab-paclitaxel in chemotherapy-naive participants with Stage IV squamous NSCLC.
DOI: 10.17632/vhv35s6tb5.1
title: Dataset for 'Hippocampal IL10/AMPK pathway is associated with the hippocampal anti-inflammatory response to high-sugar and high-fat diet withdrawal.'

description: This dataset was produced and used for the elaboration of the manuscript entitled 'Hippocampal IL10/AMPK pathway is associated with the hippocampal anti-inflammatory response to high-sugar and high-fat diet withdrawal.' It will be available after the publication of the resulting paper.

It contains the .csv file with the data used in the publication.
DOI: 10.17632/2y29bcjrxs.1
title: Dataset for the manuscript entitled: Prospective case-control study of dengue infection in some malaria and non-malaria patients consulting at the Bertoua Regional Hospital, East-Cameroon

description: The following dataset includes a set of files regarding the manuscript above-named.
DOI: 10.17632/bf49k2822m.1
title: Rhythm Training and Short-Term Memory

description: This is the data associated with the manuscript "How musical rhythm training improves short-term memory for faces"
DOI: 10.17632/nn8xj6zgst.1
title: Diagnosis of Mycosis Fungoides or Sézary Syndrome After Dupilumab Use: A Systematic Review. 

description: Supplemental materials
DOI: 10.25934/pr00006052.10
title: Available IPD datapackage for study 'A Phase III Multicenter, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Atezolizumab (MPDL3280A, Anti-PD-L1 Antibody) in Combination With Carboplatin+Nab-Paclitaxel for Chemotherapy-Naive Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer'

description: This randomized Phase III, multicenter, open-label study designed to evaluate the safety and efficacy of atezolizumab (an engineered anti-programmed death-ligand 1 [PD-L1] antibody) in combination with carboplatin+nab-paclitaxel compared with treatment with carboplatin+nab-paclitaxel in chemotherapy-naive participants with Stage IV non-squamous NSCLC. Participants will be randomized in a 2:1 ratio to Arm A (Atezolizumab+Nab-Paclitaxel+Carboplatin) or Arm B (Nab-Paclitaxel+Carboplatin).
DOI: 10.25934/pr00006051.14
title: Available IPD datapackage for study 'A Phase III, Open-Label, Randomized Study of Atezolizumab (MPDL3280A, Anti-PD-L1 Antibody) in Combination With Carboplatin+Paclitaxel With or Without Bevacizumab Compared With Carboplatin + Paclitaxel + Bevacizumab in Chemotherapy-Naïve Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer'

description: This randomized, open-label study will evaluate the safety and efficacy of atezolizumab (an engineered anti-programmed death-ligand 1 [PD-L1] antibody) in combination with carboplatin+paclitaxel with or without bevacizumab compared with treatment with carboplatin+paclitaxel+bevacizumab in chemotherapy-naïve participants with Stage IV non-squamous NSCLC. Participants will be randomized in a 1:1:1 ratio to Arm A (Atezolizumab+Carboplatin+Paclitaxel), Arm B (Atezolizumab+Carboplatin+Paclitaxel+Bevacizumab), or Arm C (Carboplatin+Paclitaxel+Bevacizumab).
DOI: 10.25934/pr00005998.3
title: Available IPD datapackage for study 'A Multistage, Phase II Study Evaluating the Safety and Efficacy of Cobimetinib Plus Paclitaxel, Cobimetinib Plus Atezolizumab Plus Paclitaxel, or Cobimetinib Plus Atezolizumab Plus Nab-Paclitaxel as First-Line Treatment for Patients With Metastatic Triple-Negative Breast Cancer'

description: This three-cohort, multi-stage, randomized, Phase II, multicenter trial will evaluate the safety and tolerability and estimate the efficacy of cobimetinib plus paclitaxel versus placebo plus paclitaxel in Cohort I, of cobimetinib plus atezolizumab plus paclitaxel in Cohort II, and of cobimetinib plus atezolizumab plus nab-paclitaxel in Cohort III in participants with metastatic or locally advanced, triple-negative adenocarcinoma of the breast who have not received prior systemic therapy for metastatic breast cancer (MBC). Participants may continue on study treatment until the development of progressive disease (PD) or the loss of clinical benefit, unacceptable toxicity, and/or consent withdrawal. The Cohort I target sample size is 12 participants for the safety run-in stage and approximately 90 participants in the expansion stage. Each of Cohorts II and III will consist of a safety run-in stage of approximately 15 participants followed by an expansion stage of approximately 15 participants.
DOI: 10.25934/pr00005598.9
title: Available IPD datapackage for study 'A Phase III, Open-Label, Multicenter, Randomized Study to Investigate the Efficacy and Safety of Atezolizumab (Anti-PD-L1 Antibody) Compared With Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer After Failure With Platinum-Containing Chemotherapy'

description: This is a Phase III, global, multicenter, open-label, two-arm, randomized, controlled study designed to evaluate the efficacy and safety of atezolizumab compared with chemotherapy in participants with locally advanced or metastatic urothelial bladder cancer (UBC) who have progressed during or following a platinum-containing regimen. The anticipated time on study treatment is based on continued clinical benefit, i.e., until disease progression or unacceptable toxicity. The target sample size is 931 participants.
DOI: 10.25934/pr00005796.8
title: Available IPD datapackage for study 'A Phase II, Multicenter, Single-Arm Study OF Atezolizumab In Patients With PD-L1-Positive Locally Advanced Or Metastatic Non-Small Cell Lung Cancer'

description: This multicenter, single-arm study will evaluate the efficacy and safety of Atezolizumab in participants with PD-L1-positive locally advanced or metastatic non-small cell lung cancer (NSCLC). Participants will receive Atezolizumab 1200 milligrams (mg) intravenously every 3 weeks as long as participants are experiencing clinical benefit as assessed by the investigator, that is , in the absence of unacceptable toxicity or symptomatic deterioration attributed to disease progression.
DOI: 10.25934/pr00005794.18
title: Available IPD datapackage for study 'A Phase III, Open-Label, Multicenter, Randomized Study to Investigate the Efficacy and Safety of Atezolizumab (Anti-PD-L1 Antibody) Compared With Docetaxel in Patients With Non-Small Cell Lung Cancer After Failure With Platinum Containing Chemotherapy'

description: This global, multicenter, open-label, randomized, controlled study evaluated the efficacy and safety of atezolizumab (an anti-programmed death−ligand 1 [anti-PD-L1] antibody)compared with docetaxel in participants with locally advanced or metastatic non-small cell lung cancer (NSCLC) after failure with platinum-containing chemotherapy. Participants were randomized 1:1 to receive either docetaxel or atezolizumab. Treatment may continue as long as participants experienced clinical benefit as assessed by the investigator, i.e., in the absence of unacceptable toxicity or symptomatic deterioration attributed to disease progression.
DOI: 10.25934/pr00005599.7
title: Available IPD datapackage for study 'A Phase II, Randomized Study of Atezolizumab (Anti-PD-L1 Antibody) Administered as Monotherapy or in Combination With Bevacizumab Versus Sunitinib in Patients With Untreated Advanced Renal Cell Carcinoma'

description: This multicenter, randomized, open-label study will evaluate the efficacy, safety and tolerability of atezolizumab as monotherapy or in combination with bevacizumab versus sunitinib in participants with histologically confirmed, inoperable, locally advanced or metastatic renal cell carcinoma who have not received prior systemic therapy either in the adjuvant or metastatic setting.
DOI: 10.25934/pr00005793.9
title: Available IPD datapackage for study 'A Phase II, Open-label, Multicenter, Randomized Study to Investigate the Efficacy and Safety of MPDL3280A (Anti−PD-L1 Antibody) Compared With Docetaxel in Patients With Non−Small Cell Lung Cancer After Platinum Failure'

description: This multicenter, open-label, randomized study will evaluate the efficacy and safety of Atezolizumab compared with docetaxel in participants with advanced or metastatic non-small cell lung cancer after platinum failure. Participants will be randomized to receive either Atezolizumab 1200 milligram (mg) intravenously every 3 weeks or docetaxel 75 milligram per meter square (mg/m^2) intravenously every 3 weeks. Treatment with Atezolizumab may be continued as long as participants are experiencing clinical benefit as assessed by the investigator, i.e., in the absence of unacceptable toxicity or symptomatic deterioration attributed to disease progression.